---
trial_id: 1503
discovery_date: 2022-07-23 22:00:47.933455
date: 2022-07-23 22:00:47.933455
title: "A Phase 2, Multi-center, Open-label, Randomized Study of Oral Asciminib Added to Imatinib Versus Continued Imatinib Versus Switch to Nilotinib in Patients With CML-CP Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular ..."
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct03578367'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
